Aeterna Zentaris Inc. [AEZS] has traded in a range of $0.29 to $1.54 in the last 1 year. As of this writing, the stock is at $0.44, up 11.72%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, AEZS shares are 7.77% up with the monthly amount drift of 47.74% and seems well in a long time frame.
On 16, November 2020, Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin. According to news published on Yahoo Finance, – Company to receive upfront payment of €5 million replacing a later stage regulatory approval milestone of U.S.$5 million – Novo Nordisk committing to fund €9 million of the budgeted AEZS-130-P02 (“Study P02”) clinical trial costs for childhood-onset growth hormone deficiency expected to be initiated in Q1 2021 .
Analyst Birdseye View:
The most recent analyst activity for Aeterna Zentaris Inc. [NASDAQ:AEZS] stock was on May 10, 2017, when it was Reiterated with a Buy rating from H.C. Wainwright, which also lowered its 12-month price target on the stock from $7.50 to $3. Before that, on July 19, 2017, Maxim Group Recapitulated a Buy rating and elevated its amount target to $4. On May 01, 2017, Maxim Group Reiterated a Buy rating and plunged its price target on this stock from $11 to $2. On January 17, 2017, Maxim Group Reiterated a Buy rating and increased its price target from $7 to $10. On December 02, 2015, H.C. Wainwright Reiterated a Buy rating and increased its price target to $12. On November 24, 2015, H.C. Wainwright Reiterated a Buy rating and boosted its amount target on this stock to $11. On November 23, 2015, Maxim Group Reiterated a Buy rating and decreased its target amount on this stock from $200 to $11. H.C. Wainwright elevated its amount target by recapitulating a higher weight for this stock.
In the past 52 weeks of trading, this stock has oscillated between a low of $0.29 and a peak of $1.54. Right now, according to Wall Street analyst the average 12-month amount target is $4.50. At the most recent market close, shares of Aeterna Zentaris Inc. [NASDAQ:AEZS] were valued at $0.44.
Aeterna Zentaris Inc. [NASDAQ:AEZS] most recently reported quarterly sales of 170.6 million, which represented growth of -66.70%. This publicly-traded organization’s revenue is $64,174 per employee, while its income is -$728,829 per employee. This company’s Gross Margin is currently 6.70%, its Pretax Margin is -1171.05, and its Net Margin is -1135.71. Continuing to look at profitability, this corporation’s Return on Assets & Whole Principal is sitting at -24.26 and -1,611.28 respectively.
It shows enduring liability to assets at 0.01 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.4083 points at 1st support level, the second support level is making up to 0.3752. But as of 1st resistance point, this stock is sitting at 0.4611 and at 0.4808 for 2nd resistance point.
Aeterna Zentaris Inc. [AEZS] reported its earnings at -$0.02 per share in the fiscal quarter closing of 9/29/2019. The Analysts for Wall Street were expecting to report its earnings at -$0.17/share signifying the difference of 0.15 and 88.20% surprise value. Comparing the previous quarter ending of 6/29/2019, the stated earnings were $0.01 calling estimates for -$0.14/share with the difference of 0.15 depicting the surprise of 107.10%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Aeterna Zentaris Inc. [NASDAQ:AEZS] is 13.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 1.39. Now if looking for a valuation of this stock’s amount to sales ratio it’s 29.49.